CHYMOTUNE-FORTE
General Range

CHYMOTUNE-FORTE

Fortune LabsPanchkula, Haryana

Price on request/100 · MOQ 100 boxes

Writing








CHYMOTUNE-FORTE Tablets by Fortune Labs contain Trypsin and Chymotrypsin, a proteolytic enzyme combination intended for selected conditions involving inflammation and tissue swelling. Trypsin and Chymotrypsin are protein-digesting enzymes investigated for their potential roles in managing postoperative swelling and injury-related discomfort. CHYMOTUNE-FORTE may be prescribed as supportive therapy following selected surgical procedures, dental treatments or soft tissue injuries when clinically appropriate. Available in convenient blister strip packaging with a printed carton box, the formulation provides an oral enzyme treatment option under healthcare professional guidance. Its use should consider the verified enzyme activity, approved indications, allergy history, bleeding disorders, possible medication interactions and recommended treatment duration. Evidence for accelerated tissue healing remains limited, and medical supervision is recommended.

CategoryGeneral Range
Min. Order100 boxes
Supplied byFortune Labs
CertificationWHO-GMP, ISO

Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.

View Company

Specifications

Composition
Trypsin Chymotrypsin Tablets
Packaging Type
Red/Brown Tablets in Blister Strips with Printed Carton Box
Packaging Size
10 × 20
Dosage Form
Tablet
Treatment
May be used as an adjunct in selected musculoskeletal injuries
Shelf Life
24 Months
Storage
Store below 30°C, protect from light & moisture
Certification
WHO-GMP, ISO

Company Info

Fortune LabsPanchkula, Haryana
View Full Profile

Fortune Labs is an Indian pharmaceutical and PCD (Propaganda Cum Distribution) pharma franchise company based in Panchkula, Haryana.

Key Details

• Headquarters: S.C.F 258, 1st Floor, Sector 16, Panchkula, Haryana, India
• Establishment: Founded in 2008 (sister concern of Prosperity 6 Pharmaceutics in Baddi)
• CEO / Leadership: Mayank Bansal
• Certifications: ISO 9001, WHO-GMP, and DCGI-approved formulations
• Business Model: Offers Pan-India PCD pharma franchises with monopoly rights, third-party manufacturing, and marketing support.

Product Portfolio & Therapeutic Ranges

• Formulations: Tablets, capsules, syrups, dry powders, injectables, ointments, gels, eye/ear/nasal drops, softgel capsules, and Ayurvedic/herbal products.
• Therapeutic Segments: Antibiotics, cardiac and diabetic care, orthopedics, dermatology, gynaecology, paediatrics, gastrointestinal/PPI ranges, neurology, antihistamines/cough-cold, and nutritional supplements.
Would you like information on how to apply for a franchise partnership or specific product price lists from Fortune Labs?

More General Range